| Lauren Burningham, SLP-CF | |
|
2422 20th St Sw, Jamestown, ND 58401-6201 | |
| (701) 952-4800 | |
| Not Available |
| Full Name | Lauren Burningham |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2422 20th St Sw, Jamestown, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780179572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1667 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Burningham, SLP-CF 2422 20th St Sw, Jamestown, ND 58401-6201 Ph: (701) 952-4800 | Lauren Burningham, SLP-CF 2422 20th St Sw, Jamestown, ND 58401-6201 Ph: (701) 952-4800 |
News Archive
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first commercial implants of the ATS 3f Enable® Aortic Bioprosthesis were recently performed at the University of Berne Hospital, Berne, Switzerland by Lars Englberger, MD, Mario Stalder, MD, and Professor Thierry Carrel. The procedures were completed using a sutureless technique and the patients are recovering with no complications.
Hana Biosciences Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has entered into an Investment Agreement with Warburg Pincus and Deerfield Management for the sale of up to $100 million in preferred stock. Warburg Pincus, the lead investor in the financing, is a new investor in Hana, and Deerfield is the company's largest existing shareholder prior to this financing.
A new analysis has found that a type of radiation therapy called carbon ion radiotherapy can control cancer growth and prolong survival in patients with spinal tumors. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that the treatment is a promising alternative for patients whose spinal tumors cannot be surgically removed.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 3 days ago
Laurie Anne Schauer, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850 Fax: 701-952-5154 | |
Adeline Eamon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-568-5175 | |
Lori Dawn Love, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850 Fax: 701-952-5154 | |
Stephanie Joy Nelson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850 Fax: 701-952-5154 | |
James Harold George Bergman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850 | |
Ashley Ann Boom, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 2nd Ave Sw, Jamestown, ND 58401 Phone: 701-252-6066 | |
Andy Kolff, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376 |